A significant decline in IGF-I may predispose young africans to subsequent cardiometabolic vulnerability

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2503-2507

  Schutte, Aletta E ^a   Huisman, Hugo W ^a   Van Rooyen, Johannes M ^a   Malan, Leoné ^a   Malan, Nico T ^a   Fourie, Carla M T ^a   Louw, Roan ^a   Van Der Westhuizen, Francois H ^a   Schutte, Rudolph ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; C REACTIVE PROTEIN; COTININE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIVER ENZYME; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NEGRO; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD PRESSURE; ENZYMOLOGY; GENETICS; LIVER; METABOLISM; MIDDLE AGED; RISK FACTOR; SOUTH AFRICA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; MIDDLE AGED; RISK FACTORS; SOUTH AFRICA; TRIGLYCERIDES; YOUNG ADULT;

EID: 77952777296     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2329     Document Type: Article

References (20)

1. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
2. Vardatsikos G, Sahu A, Srivastava AK 2009 The insulin-like growth factor family: molecular mechanisms, redox regulation and clinical implications. Antioxid Redox Signal 11:1165-1190
3. Perticone F, Sciacqua A, Perticone M, Laino I, Miceli S, Care' I, Galiano Leone G, Andreozzi F, Maio R, Sesti G 2008 Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endocrinol Metab 93:2806-2810 (Pubitemid 352008555)
4. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D 1999 Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 29:758-769
5. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW 2003 Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 139:642-648
6. Kenyon C 2005 The plasticity of aging: insights from long-lived mutants. Cell 120:449-460
7. World Health Organization 2009 South Africa. http://www.who.int/ countries/zaf/en/
8. Bradshaw D, Norman R, Pieterse D, Levitt NS 2007 Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J 97:700-706
9. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S 2008 Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915-922
10. Melikian N, Wheatcroft SB, Ogah OS, Murphy C, Chowienczyk PJ, Wierzbicki AS, Sanders TA, Jiang B, Duncan ER, Shah AM, Kearney MT 2007 Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young black African men. Hypertension 49:873-877
11. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T 2007 High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res 631:55-61 (Pubitemid 46809621)
12. Yamamoto H, Sohmiya M, Oka N, Kato Y 1991 Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol (Copenh) 124:497-500
13. Hilding A, Hall K, Wivall-Helleryd IL, Sääf M, Melin AL, Thorén M 1999 Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84:2013-2019
14. Schini-Kerth VB 1999 Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. J Endocrinol Invest 22:82-88
15. Conti E, Andreotti F, Sestito A, Riccardi P, Menini E, Crea F, Maseri A, Lanza GA 2002 Reduced levels of insulin-like growth factor-1 in patients with angina pectoris, positive exercise stress test, and angiographically normal epicardial coronary arteries. Am J Cardiol 89:973-975
16. Spies M, Nesic O, Barrow RE, Perez-Polo JR, Herndon DN 2001 Liposomal IGF-I gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound. Gene Ther 8:1409-1415
17. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C, Andreotti F 2004 Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260-2265
18. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P 2007 IGF-I reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27:2684-2690
19. Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E 1999 Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 8:1107-1110
20. Camidge DR, Dziadziuszko R, Hirsch FR 2009 The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers. Clin Lung Cancer 10:262-272